FNICX | GAFFX | FNICX / GAFFX | |
Total Expense Ratio | 1.65 | 0.30 | 550% |
Annual Report Gross Expense Ratio | 1.65 | 0.30 | 550% |
Fund Existence | 22 years | 9 years | - |
Gain YTD | 11.517 | 13.509 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.4B | 328B | 7% |
Annual Yield % from dividends | 0.03 | 0.61 | 5% |
Returns for 1 year | 16.79 | 18.19 | 92% |
Returns for 3 years | 43.73 | 59.69 | 73% |
Returns for 5 years | 17.65 | 50.79 | 35% |
Returns for 10 years | 30.35 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BCHP | 37.87 | 0.18 | +0.48% |
Principal Focused Blue Chip ETF | |||
CGCP | 22.46 | 0.04 | +0.18% |
Capital Group Core Plus Income ETF | |||
TBUX | 49.90 | 0.03 | +0.05% |
T. Rowe Price Ultra Short-Term Bond ETF | |||
MSTQ | 36.89 | -0.02 | -0.05% |
LHA Market State™ Tactical Q ETF | |||
LFSC | 24.72 | -0.03 | -0.10% |
F/m Emerald Life Sciences Innovation ETF |